James E. Balow spends much of his time researching Lupus nephritis, Internal medicine, Lupus erythematosus, Immunology and Gastroenterology. His work carried out in the field of Lupus nephritis brings together such families of science as Cyclophosphamide, Surgery, Chemotherapy, Prednisone and Systemic lupus erythematosus. The various areas that James E. Balow examines in his Internal medicine study include Endocrinology, Nephropathy and Pathology.
He studied Lupus erythematosus and Connective tissue disease that intersect with Immunopathology. His study looks at the relationship between Immunology and fields such as Proteinuria, as well as how they intersect with chemical problems. His work deals with themes such as Azotemia, Rasburicase, Hemodialysis, Dialysis and Hyperphosphatemia, which intersect with Gastroenterology.
His primary scientific interests are in Immunology, Internal medicine, Lupus nephritis, Lupus erythematosus and Gastroenterology. The Immunology study combines topics in areas such as Cytotoxic T cell and Peripheral blood mononuclear cell. His studies examine the connections between Internal medicine and genetics, as well as such issues in Endocrinology, with regards to Interleukin 2 and In vitro.
His research investigates the link between Lupus nephritis and topics such as Cyclophosphamide that cross with problems in Methylprednisolone. His Lupus erythematosus study also includes fields such as
Immunology, Internal medicine, Lupus nephritis, Systemic lupus erythematosus and Gastroenterology are his primary areas of study. His study in Immunology is interdisciplinary in nature, drawing from both Kidney, Gene and Membranous nephropathy. He interconnects Endocrinology and Nephropathy in the investigation of issues within Internal medicine.
His Lupus nephritis research incorporates elements of Medical record, Confidence interval, Azathioprine, Physical therapy and Nephritis. As a part of the same scientific study, he usually deals with the Systemic lupus erythematosus, concentrating on Lupus erythematosus and frequently concerns with Connective tissue disease. His Gastroenterology study deals with Randomized controlled trial intersecting with Tolerability, Adverse effect, Omalizumab, Immunoglobulin E and Autoantibody.
His primary areas of study are Internal medicine, Immunology, Lupus nephritis, Systemic lupus erythematosus and Kidney. His study looks at the relationship between Internal medicine and topics such as Nephropathy, which overlap with Pathology, Nephrology, Kidney disease and Focal segmental glomerulosclerosis. His work carried out in the field of Immunology brings together such families of science as Gastroenterology, Open label and Receptor Inhibition.
His studies deal with areas such as Cancer research, Suppressor of cytokine signaling 1, Nephrotic syndrome, miR-150 and Proteinuria as well as Lupus nephritis. The study incorporates disciplines such as Chronic granulomatous disease, Anti-nuclear antibody, Autoimmune disease, Antiphospholipid syndrome and Lupus erythematosus in addition to Systemic lupus erythematosus. His biological study spans a wide range of topics, including Fibrosis, Downregulation and upregulation and Medical record.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Jan J. Weening;Vivette D. D'Agati;Melvin M. Schwartz;Surya V. Seshan.
Journal of The American Society of Nephrology (2004)
Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever
I. Aksentijevich;M. Centola;Z. M. Deng;R. Sood.
Cell (1997)
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
H. A. Austin;J. H. Klippel;J. E. Balow;N. G.H. Le Riche.
The New England Journal of Medicine (1986)
Enzyme replacement therapy in Fabry disease: a randomized controlled trial.
Raphael Schiffmann;Jeffrey B. Kopp;Howard A. Austin;Sharda Sabnis.
JAMA (2001)
Glucocorticosteroid Therapy: Mechanisms of Action and Clinical Considerations
Anthony S. Fauci;David C. Dale;James E. Balow.
Annals of Internal Medicine (1976)
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Dimitrios T. Boumpas;George P. Chrousos;Ronald L. Wilder;Thomas R. Cupps.
Annals of Internal Medicine (1993)
Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.
N Zaks;JE Balow;E Mansfield;M. E. Mangelsdorf.
Cell (1997)
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis
D.T. Boumpas;H.A. Austin;J.E. Balow;E.M. Vaughan.
The Lancet (1992)
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
Ivona Aksentijevich;Miroslawa Nowak;Mustapha Mallah;Jae Jin Chae.
Arthritis & Rheumatism (2002)
Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.
Howard A. Austin;Larry R. Muenz;Kathleen M. Joyce;Tatiana T. Antonovych.
Kidney International (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Beth Israel Deaconess Medical Center
National and Kapodistrian University of Athens
Mitre (United States)
National Institutes of Health
National Institutes of Health
Hospital for Special Surgery
Sheba Medical Center
National Institutes of Health
Cornell University
National Institutes of Health
Rutgers, The State University of New Jersey
Hitachi (Japan)
University of Salerno
University of Kansas
Agricultural Research Service
University of California, San Diego
University of Copenhagen
Heidelberg University
Sapienza University of Rome
Harvard University
University of Tübingen
Beijing Institute of Technology
Ruhr University Bochum
Erasmus University Rotterdam
The Royal Free Hospital
North Carolina State University